Powered by

-Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update

Mar 16, 2021 - ENP Newswire
Financial Results

CORAL GABLES - Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today reported financial results for the fourth quarter and year ended December 31, 2020 and provided a corporate update.

'We are extremely pleased with our continued commercial execution of the Firdapse launch during 2020...